EURX Eurand N.V. (MM)

Event: 2010 Credit Suisse Healthcare Conference Date: Friday, November 12, 2010 Time: 8:00 a.m. MT (Presentation by Eurand Chief Commercial Officer John Fraher) Place: Arizona Biltmore 2400 East Missouri Avenue Phoenix, Ariz.

Event: Barclays Capital Healthcare Small- and Mid-Cap One-on-One Day Date: Thursday, November 18, 2010 Time: 8:00 a.m. to 5:00 p.m. CT (Individual Meetings -- Time is Approximate) Place: Graves 601 Hotel 601 First Avenue North Minneapolis, Minn.

An audio webcast of the Company's presentation at the Credit Suisse Conference will be available by accessing the investor relations section of www.eurand.com and will be available via replay for 30 days following the date of the presentation.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com.

Contacts: Bill Newbould Vice President, Investor Relations Eurand N.V. +1-267-759-9335 Email Contact Nick Laudico/Sara Pellegrino The Ruth Group +1-646-536-7030/7002 Email Contact Email Contact

Eurand N.V. (MM) (NASDAQ:EURX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Eurand N.V. (MM) (NASDAQ:EURX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024